Denis Kibira

Class of:

2016

Current affiliation:

HEPS Uganda

Contact:

dkibira@gmail.com

Motivation:

“The future belongs to those who believe in the beauty of their dreams.”– Eleanor Roosevelt

Education and experience:

Denis Kibira is a graduate of Advanced Health Management Program from Yale School of Public Health/ Foundation for Professional Development, has a Master in Business Administration degree from Uganda Martyrs University and holds a Bachelor of Pharmacy degree from the Rajiv Gandhi Technical University in India.

Is the Executive Director at the Coalition for Health Promotion and Social Development (HEPS Uganda); also Regional Coordinator for the Health Systems Advocacy program at Health Action International (HAI). Denis possesses extensive experience in health and pharmaceutical systems, policy, research and advocacy. He has coordinated the Medicines Transparency Alliance (MeTA) in Uganda since 2012 and was secretariat member from 2008.

Denis has research experience of over 50 researches including national household and health facility assessment surveys in Uganda and is a civil society activist. A member of Pharmaceutical Society of Uganda and the South African Institute of Healthcare Managers.

Title PhD project: 

Global Health Agenda and Access to Sexual Reproductive Health medicines and supplies in Low and Middle Income Countries (LMICs).

PhD project description:

Africa accounts for 25% of the global disease burden, the bulk of the global infectious disease burden (75% of HIV/AIDS pandemic, 90% of malaria cases and deaths) and more than 50% of the global deaths of children under five, yet it consumes only 1% of global healthcare expenditure (World Bank, 2007). According to WHO, every day 800 women worldwide die of complications during pregnancy and childbirth and the majority (99%) of these deaths occur in developing countries and almost all could have been prevented by proper health services and commodities (WHO, 2014).

According to the WHO, expenditure on medicines accounts for a major proportion of health costs in developing countries; trade in medicines is increasing rapidly but most of it takes place between wealthy countries, with developing countries accounting for just 17% of imports and 6% of exports. It is estimated that one-third of the developing world’s people are unable to receive or purchase essential medicines on a regular basis.

A number of global institutions and governments have made commitments to support access to health services and commodities in low and middle income countries (LMICs). The PhD project will assess impact of the various interventions by global institutions and governments with a focus on access to SRH commodities in three African countries of Uganda, Kenya and Zambia.

Teammembers and other people involved:

Prof. Dr. Bert Leufkens, Dr. Aukje Mantel-Teeuwisse, Dr. Rianne van den Ham, Tim Reed.

 

Publications:

———-